Disease | Gene | Inheritance | Clinical features | Laboratory tests | Treatment |
---|---|---|---|---|---|
HLH | PRF1; UNC13D; STX11; STXBP2. | AR | Fever, hepatosplenomegaly, lymphadenopathy, cytopenia, serositis, hepatic and CNS involvement | Increased levels of ferritin, triglycerides, d-dimer; Increased CRP, SAA, low ESR during disease flares; Cytopenia, low levels of fibrinogen, inactivity of natural killer cells, increased sIL2R; Presence of hemophagocytosis on myelogram or tissue biopsy | CS, IL-1i, Ig, etoposide, HSCT; Control of infectious agents |
Langerhans cell histiocytosis¶ | BRAF V600E; MAPK. | Somatic mutation | Pruritic or ulcerative skin rashes, interstitial lung disease (cystic pattern), liver, spleen and/or bone marrow involvement | CD1a + Langerin + Langerhans cell Infiltration, CD1a + Langerin with + with BRAF V600E+ (50-60%) and eosinophils; Electron microscopy with Birbeck granules | Vinblastine + CS/ Cladribine + Cytarabine, Vemurafenib; Quit smoking |
Erdheim-Chester disease | BRAF V600E; MAPK. | Somatic mutation | Diaphyseal osteolytic lesions, coated aorta, renal lesion (hairy kidney), proptosis, cardiac and nervous system involvement | Touton cells on biopsy, histiocytes stained with CD68 + and CD1a- and S100- markers, BRAF V600E positive in tissue sample | Gamma interferon, Cyclophosphamide, Vemurafenib, Cladribine, Infliximab, Anakinra, Tocilizumab |
Rosai-Dorfman disease | MAPK; KRAS. | Somatic mutation | Localized or disseminated painful lymph node enlargement, retroorbital or skin involvement., autoimmune or neoplastic manifestations may be associated | Sinusoidal expansion in the lymph nodes; Emperipolesis or storiform fibrosis may be present in the tissue; Histiocytes CD68+, CD1a -, S100+; IgG4 + in some cases | Sporadic remission in 50% of cases; Unifocal: Surgical excision; Multifocal: CS, Sirolimus, Chemotherapy, MAPK inhibitor |
Kikuchi-Fujimoto disease | ----* | ----* | Fever, painful lymphadenopathy usually cervical, hepatosplenomegaly, arthralgia. may be associated with autoimmune diseases (SLE) | Increased IM during disease flares, leukopenia, atypical lymphocytes in peripheral blood. Clusters of small lymphocytes, histiocytes CD68+, immunoblasts and plasma cells in the absence of neutrophils with necrosis; Abundant karyorrhectic | Sporadic remission for self-limited disease, CS or surgical excision for severe clinical features |
Multicentric reticulohistiocytosis | ----* | ----* | Skin papules and nodules on face, periungual nodules and papules (coral bead appearance), fever, xanthelasma, destructive arthritis (proximal interphalangeal DIP predominance); Autoimmune and neoplastic manifestations diseases may be associated | Increased IM during disease flares, hyperlipidemia and hypergammaglobulinemia; Positive RF, ANA, or CCP is rarely observed. Histiocytic multinucleated CD68+, CD1a-, S100- | CS, methotrexate, bisphosphonates, cyclophosphamide, TNF-inhibitors, Chemotherapy in cases with malignancy |
Macrophage activation syndrome | ----* | ----* | Fever, hepatosplenomegaly, cytopenia, lymphadenopathy, hepatic and nervous system involvement | Increased levels of ferritin, triglycerides, d-dimer, cytopenia, low levels of fibrinogen, low/absent NK cell activity, increased sIL2R; Presence of hemophagocytosis on myelogram or tissue biopsy | CS, Ig, IL-1i, tocilizumab, cyclosporine, etoposide, control of infectious agents |